AED recalls
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Science, Inc. initiates 5,530-unit recall of Powerheart 9200RD and 9210RD automatic external defibrillators during the week of May 24, the Irvine, Calif. company discloses June 1 in an 18-K filing with the SEC. So far, 650 AEDs containing faulty capacitors have been identified in the field through the devices' RescueReady indicator. Cardiac Science's decision to recall the remaining AEDs resulted from a corrective and preventive action (CAPA) analysis following a March 29 FDA warning letter. The firm notes that itsG3 line, 510(k)-cleared in July 2003, is unaffected. G3 accounts for 95% of Cardiac Science's AED sales. Cardiac Science also reports that a 4,730-battery recall and replacement begun May 4 "has been substantially completed." The G3 battery error originated with the firm's supplier, according to Cardiac Science, which estimates total costs from both recalls at $1 mil.-$1.5 mil., with potential battery reimbursement coming from suppliers. In April, Medtronic recalled LifePak AEDs for battery malfunctions and announced a Class I ICD recall due to a faulty capacitor...
You may also be interested in...
Zeiss Visulink Reflects Rise In Device Class I Recall Notifications
Carl Zeiss Meditec's Class I voluntary recall is part of a recent uptick in FDA announcements related to the most serious type of device recalls
Over-The-Counter Defibrillator, AED Adverse Events To Be Gauged By Panel
FDA panel recommendations at a July 29 meeting to consider an OTC indication for an automated external defibrillator will affect only the product under review. Manufacturers of other approved systems will have to file data separately with CDRH to earn over-the-counter status, according to the agency
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.